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Abstract  
Self-assembling peptides (SAPs) have shown to offer great promise in therapeutics and have the 
ability to undergo self-assembly and form ordered nanostructures. However SAP gels are often 
associated with inherent weak and transient mechanical properties and incorporation of them into 
polymeric matrices is a route to enhance their mechanical stability. The aim of this work was to 
incorporate P11-8 peptide (CH3COQQRFOWOFEQQNH2) within poly(ε-caprolactone) (PCL) 
fibrous webs via one-step electrospinning, aiming to establish the underlying relationships between 
spinning process, molecular peptide conformation, and material internal architecture. 
Electrospinning of PCL solutions (6% w/w) in hexafluoro-2-propanol (HFIP) containing up to 40 
mg∙mL-1 P11-8 resulted in the formation of fibres in both nano- (10-100 nm) and submicron range 
(100-700 nm), in contrast to PCL only webs, which displayed a predominantly submicron fibre 
distribution. FTIR and CD spectroscopy on both PCL/peptide solutions and resulting electrospun 
webs revealed monomeric and β-sheet secondary conformation, respectively, suggesting the 
occurrence of peptide self-assembly during electrospinning due to solvent evaporation. The peptide 
concentration (0  40 mg∙mL-1) was found to primarily affect the internal structure of the fabric at 
the nano-scale, whilst water as well as cell culture medium contact angles were dramatically 
decreased. Nearly no cytotoxic response (> 90% cell viability) was observed when L929 mouse 
fibroblasts were cultured in contact with electrospun peptide loaded samples. This novel 
nanofibrous architecture may be the basis for an interesting material platform for e.g. hard tissue 
repair, in light of the presence of the self-assembled P11-8 in the PCL fibrous structure.  
Keywords: Self-assembly, β-sheet, Electrospinning, Biomaterial, Cytotoxicity   
Introduction 
Peptide self-assembly has been the focus of research in the last two decades in light of their 
potential application in hard and soft tissue repair as well as in controlled drug delivery.
1-4
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Rationally designed SAPs are composed of amino acidic building blocks that can mimic specific 
molecular features of the extracellular matrix (ECM) of tissues, such as the RGD cell-binding 
peptide sequence,
2
 and facilitate the enhancement of cell growth in the biomaterial.
3, 5, 6
 Designing 
different primary peptide structures by applying various amino acid side chains and altering peptide 
sequences, enables the physical and biological properties of peptides to be tuned according to the 
intended end use.
2
   
The 11-residue family of peptides (P11-X) consists of negatively or positively charged 
hydrogelating materials and self-assemble hierarchically into long β-sheet tapes (a single-molecule 
thick), ribbons (two stacked tapes), fibrils (multiple stacks of ribbons) and entwined fibrils (referred 
to by some as fibres), following application of external stimuli.
6
 Above a critical concentration (c*), 
peptide monomers assemble into hydrogen bonded β-sheet tapes, with higher order structures being 
produced if the concentration is further increased. This class of peptides also undergoes pH
7
 and 
ionic strength-triggered
8
 self-assembly which is relevant for their applicability as drug delivery 
vehicles. So far, most of the published studies using P11-X peptides have focused on the molecular 
design of self-supporting gels, whereby promising properties have been shown with regard to cell 
growth and hard tissue deposition.
2, 3, 6, 9
 Furthermore peptide P11-8 (+2 charge) has shown low 
immunogenicity in vivo,
10
 no cytotoxic effect to human and murine cells
6, 11
 and enhanced bone 
tissue regeneration. However, despite their inherent biofunctionality, self-assembled peptide gels 
frequently suffer from poor mechanical strength and lack of structural stability. This potentially 
makes their handling and fixation during implantation in vivo challenging, particularly in large load-
bearing tissue defects. Attaining mechanically-competent scaffolds capable of supporting cell 
growth spatially and temporally until the newly engineered tissue is formed, is one of the major 
challenges in the design of SAP-based medical devices.
12
 The incorporation of SAPs within water-
stable synthetic fibres is a potential route to address this challenge, and to deliver structurally 
reinforced fabrics. 
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Electrospinning is an established technique for the production of polymeric nanofibres, the 
fundamentals of which have been known since the work of Formhals in the 1930s.
13
  Electrospun 
webs have high solid surface area to volume ratio and high porosity and control of fibre 
morphological and topographical features is readily achieved by varying process parameters.
14
 
Their application as tissue scaffolds has been extensively studied.
13, 15-18
 In addition to the structural 
features that can mimic fibrous architecture of the ECM
19
, the material composition should be 
nontoxic and induce the intended response on tissue components in vivo or in vitro.
16
  
A variety of synthetic and natural polymers alone or in blends has been successfully electrospun 
resulting in fibres with diameters ranging from the micron up to the nanometre scale,
5, 16, 20-26
 whilst 
voltage-free spinning techniques have also been recently employed for the formation of single 
biomimetic fibres.
27, 28
 Biocompatible synthetic polymers that have been successfully electrospun 
include aliphatic linear polyesters such as polyglycolic acid (PGA),
29
 polylactic acid (PLA)
30, 31
 and 
PCL.
32, 33
 Among these, PCL can be used in FDA approved devices i.e. for applications in the 
human body such as drug delivery and tissue engineering.
32, 34
 PCL is low-cost, non-toxic and 
biodegrades slowly depending on the molecular weight. PCL has been extensively investigated in 
relation to various biomedical applications, including regenerative therapies,
23, 25, 35-37
 whilst 
showing supporting the attachment and growth of muscle cells, mesenchymal stem cells, and 
chondrocytes.
32, 38-40
 However, due to the lack of cell-binding sequences along its polymeric 
backbone and its hydrophobicity, PCL must be modified via e.g. plasma treatment and/or 
coating.
32,41,42
  
In addition to synthetic polymers, the self-assembly of some (poly-)peptides and proteins was 
exploited using electrospinning, aiming to accomplish biomimetic and unusual architectures. 
Nuansing et al.
43
 attempted to electrospin a short peptide of Fmoc-FG (Fmoc–Phe–Gly) which 
resulted in rough fibres with diameters of around 300 nm, while Haynie et al.
15
 successfully 
electrospun polypeptides of poly(L-ornithine) (PLO) and poly(L-glutamic acid4-co-L-tyrosine) 
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(PLEY) resulting in fibres with diameters ranging from 0.1µm to several microns. Tayi et al.
44
 also 
attempted to electrospin peptide amphiphiles (PAs) into micrometre-scale fibres without a polymer 
carrier. In all of these studies, in addition to the serious challenges involving the optimisation of the 
spinning solution as well as electrospinning process parameters, the resulting pure electrospun 
(poly)- peptides webs were not mechanically robust such that they are not easy to handle for clinical 
use. Since the self-assembly is only stabilised by weak non-covalent bonds, resulting architectures 
can only partially be customised, so that electrospinning of classical synthetic polymers, e.g. PCL, 
has been studied in the presence of bioactive SAPs. Andukuri et al.
41
 coated electrospun PCL fibres 
with peptide amphiphiles (PAs) for cardiovascular implants, whereby PAs were self-assembled at 
the surface of the nanofibres by a solvent evaporation technique. Significant improvement was 
observed in adhesion and proliferation of human umbilical vein endothelial cells (HUVECs), 
however there were limitations in smooth muscle cell proliferation and adhesion of platelet cells.
41
 
In another study, electrospun PCL scaffold was covalently modified by perlecan domain IV peptide, 
and this approach led to significantly enhanced cell adherence and infiltration in a 3-D 
pharmacokinetic cancer model.
42
 To avoid the post-treatments, the biofunctional components can 
also be directly blended with the polymer in solutions to fabricate electrospun fibres in one step. A 
single step electrospinning of mixture of poly(lactic-co-glycolic acid) (PLGA) and peptide 
(CGGRGDS) has been demonstrated by Gentsch et al.
45
, which resulted in fibre surface enrichment 
with peptide. In other approaches, PCL/peptide conjugates were electrospun to specifically and non-
covalently guide the spatial arrangement of biomolecules such as glycosaminoglycans (GAGs) 
within the scaffold, so that biological gradients found in native tissues could be successfully 
mimicked.
46
 Further to that, a variety of self-assembling peptides (EAK, DAK, EAbuK, EYK, 
RGD-EAK, and RGD-EAKsc) have been added into PCL solutions prior to electrospinning.
20
 The 
resulting fibres containing peptide not only exhibited higher surface wettability and amorphous 
phase compared to that of PCL, but there was also an improvement in h-osteoblast cell adhesion. 
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The aim of this work was to investigate whether a structurally stable fibrous architecture could be 
accomplished in one-step via (i) electrospinning of a HFIP solution of both peptide P11-8 and PCL 
and (ii) molecular peptide self-assembly during fibre formation. P11-8 peptide was added into a 
HFIP solution of PCL. HFIP was selected as electrospinning solvent in light of its fast evaporation 
and ability to break down hydrophobic interactions and hydrogen bonds,
47
 so that clear solutions of 
PCL and P11-8 random coils could be obtained. Electrospun webs were inspected by SEM and 
TEM, revealing the formation of both submicron (diameter of 100-700 nm) and nanofibres 
(diameter of 10-100 nm), whilst homogeneously distributed submicron fibres were observed in the 
case of PCL web controls. The secondary conformation of peptide before and after electrospinning 
and the mechanism behind the formation of a secondary peptide concentration-dependent nano-
architecture in PCL/P11-8 electrospun webs was elucidated via spectroscopic analysis. Resulting 
fibres were then cultured with L929 mouse fibroblasts and cell response were analysed in terms of 
cytotoxicity and metabolic activity. 
 
Experimental Methods 
Preparation of PCL and P11-8 spinning solution. PCL (Mn: 80,000 g.mol
-1
) and HFIP (purity ≥ 
99.0%) were purchased from Sigma Aldrich UK. Peptide P11-8 (CH3CO-Gln-Gln-Arg-Phe-Orn-
Trp-Orn-Phe-Glu-Gln-Gln-NH2 (peptide content ~ 75%, HPLC purity of 96%) was purchased from 
CS Bio Co. (USA). The peptide product dry weight reflects 25% non-peptide content, ascribed to 
residual amount of water and trifluoroacetic acid (TFA) counterions bound to positively charged 
groups. Fluorescein--Ala–P11-4 (Fluorescein--Ala-Gln-Gln-Arg-Phe-Glu-Trp-Glu-Phe-Glu-Gln-
Gln-NH2 (HPLC purity 95.1%) was purchased from PolyPeptide (France). The electrospinning 
solutions were prepared by dissolving 6% (w/w) PCL in HFIP at room temperature. After magnetic 
stirring for 24 h, either 10, 20 or 40 mg of P11-8 was added into 1 mL of the PCL solution and they 
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were left for 24 h until homogeneous mixtures were obtained. A control solution of only PCL in 
HFIP (6% w/w) was also prepared.  
Preparation of PCL and P11-8 fibre webs via electrospinning. A standard single spinneret 
electrospinning setup consisting of a syringe connected to high voltage power supply (Glassman 
Inc.), a grounded collector and a syringe pump (Kd Scientific Model 200 Series) was used in this 
study. The solutions were released from a 5 mL glass syringe fitted with a 22 gauge blunt tipped 
needle (Sigma Aldrich) at a rate of 1 mL.h
-1
. Electrospinning was carried out at a distance between 
needle and collector of 18 cm with a voltage of 20 kV, enabling the formation of smooth and 
uniform fibres with no beads. An ambient temperature of 21 ± 2°C and a relative humidity of 43 ± 
2% were consistently recorded in the spinning chamber. Fibres were collected on an aluminium foil 
of 15×15 cm and after deposition they were dried in room temperature under vacuum for 7 days to 
ensure evaporation of all solvent residues. Sample nomenclature is defined in Table 1. 
 
Table 1. Sample nomenclature and formulation used in this study. All samples were prepared from a HFIP 
solution of PCL (6% w/w). 
Sample ID Sample specification 
1 PCL ([P11-8]: 0 mg.mL
-1
) 
2 PCL/P11-8 ([P11-8]: 10 mg.mL
-1
) 
3 PCL/P11-8 ([P11-8]: 20 mg.mL
-1
) 
4 PCL/P11-8 ([P11-8]: 40 mg.mL
-1
) 
5 PCL/P11-8/fluoro P11-4 ([P11-8]: 20 mg.mL
-1
 and [fluoro P11-4]: 330 µg.mL
-1
) 
 
 
CD & FT-IR Spectroscopy. FTIR and CD were used to determine the secondary structure of the 
peptide in both solution and fibre state.
48, 49
 The solution for CD and FTIR analysis was prepared in 
a similar manner to that used for electrospinning by dissolving 20 mg of P11-8 in 1 mL solution of 
PCL in HFIP (6% w/w) (sample 3). FTIR of the solution was performed with a Nicolet 6700 FTIR. 
The sample was held onto CaF2 windows and 32 scans were performed and measurements taken in 
the range 4000 – 400 cm-1. The HFIP solvent spectrum (blank) was subtracted from the spinning 
solution spectrum. CD spectra were recorded using a Chirascan CD spectrometer (Applied 
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Photophysics) and the solutions were analysed in 1 mm path length cuvettes at 22°C (spinning 
conditions). The data was acquired at a step resolution of 1 nm with a scan speed of 60 nm.min
-1 
and a bandwidth of 4.3 nm. Far UV spectra were recorded over the wavelength range 190 to 240 
nm. Each spectrum shown herein was the average of two scans. The HFIP (blank) spectrum was 
subtracted from the peptide-containing spinning solution spectrum. The data then were converted to 
mean residue molar ellipticity (deg.cm
2
.dmol
-1
) and finally a 7
th
 order polynomial fitting was 
performed (R
2
= 0.95). Infrared spectra of PCL/P11-8 fibres (sample 3) deposited on aluminium foil 
were obtained using a Perkin Elmer FTIR with diamond Attenuated Total Reflectance (ATR) 
attachment system. A total of 64 scans were averaged for each spectrum in the range between 4000 
and 400 cm
-1
. 
Electron Microscopy (SEM & TEM). Dry electrospun samples were sputter coated with 
platinum with a thickness of 8 nm and imaged using a field emission gun scanning electron 
microscope (LEO1530 Gemini). The microscope was provided with an energy-dispersive X-ray 
spectrometer (EDX) of Oxford Instruments AztecEnergy to investigate the chemical composition of 
the as-spun materials. To more extensively investigate the nano- and submicron architecture, a thin 
layer of the fibres were directly electrospun onto transmission electron microscopy (TEM) grids 
(mounted on aluminium foil) and TEM analysis was performed using a FEI Tecnai TF20. The TEM 
microscope was also fitted with an EDX system (Oxford Instruments INCA 350). Three random 
spots per sample was tested for EDX spectroscopy. PCL and PCL/P11-8 electrospun fibre 
dimensions (sample 1 and 3) were measured using multiple SEM images by Image Pro Plus 6.2.1 
software (Media Cybernetics) with at least 100 measurements per sample to determine mean fibre 
diameter and associated frequency distributions. Values were expressed as mean ± standard error. 
Confocal laser scanning microscopy (CLSM). To investigate the peptide distribution 
throughout the fibres, the P11-8 peptide in the spinning solution was doped with P11-4 functionalised 
by a fluorescein moiety [ratio of fluoro P11-4:P11-8 = 1:60] to facilitate viewing by confocal 
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microscopy. Functionalised P11-4 was used in this case to produce a polyelectrolyte -sheet 
complex. Mixing an anionic and cationic peptide is an alternative way to induce self-assembly,
50
 
which in this case was the preferred method to ensure full mixing of the fluoro tagged peptide. A 
large fluorescein moiety will have a high degree of steric hindrance which would, in an anionic – 
anionic system phase separate and exclude itself from the bulk of the -sheet structures formed. 
Both the blank (sample 1) and fluoro P11-4 doped peptide-loaded sample (sample 5) were observed 
by confocal laser scanning microscopy of Zeiss LSM510. 
Surface Wettability. PCL and PCL/P11-8 fibres and cast films were tested for contact angle 
measurement using goniometry (FTA 4000 Microdrop®). 1.5 𝜇L drop of either deionised water 
(Milli-Q) or Dulbecco's Modified Eagle's medium (DMEM) was deposited and the contact angles 
over 15 s were measured. Three replicates per sample were examined. Values were expressed as 
mean ± standard error. Films were also prepared to investigate the surface wettability of the non-
porous material. PCL and PCL/P11-8 solutions in HFIP were cast on glass slides and films were 
prepared by drying under vacuum for 48 hours. Contact angle measurements were carried out with 
deionised water and results expressed as described above. 
Direct Cytotoxicity assay. Fibres were prepared in the same manner as previously described and 
sterilised by gamma irradiation. Samples of 10×10 mm were cut out for evaluation. PCL (sample 1) 
was used as negative control because of its non-cytotoxicity
32, 37
 and the PCL/ P11-8 (sample 3) was 
used to test the cytotoxic response of P11-8 directly in contact with L929 cells. L929 mouse 
fibroblast cells were cultured in DMEM (Dulbecco’s modified eagle’s medium) with 10% foetal 
bovine serum and 1% Penicillin/Streptomycin (P/S) until confluence (5% CO2, 37℃). Gamma-
sterilised, DMEM-soaked samples were singularly placed on the wells of a 24-well plate in which 
cells with a seeding density of 10
5
 cells.mL
-1
 had been cultured for 24 h with verified sub-
confluency (n=6). The culture medium was then replaced in each well with 500 µL of fresh 
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DMEM. Alternatively 250 µL DMEM and 250 µL DMSO (Dimethyl sulfoxide, purity≥ 99.9) was 
added in positive control wells. Plates were incubated for 48 h at 37ºC in 5% (v/v) CO2 in air. The 
PCL and PCL/P11-8 samples in contact with cells were examined under a phase-contrast microscope 
(Leica DFC365 FX). After aspirating the culture medium and washing the samples with PBS, 200 
µL of filter sterilised MTT solution (1 mg.mL
-1 
of (3-(4, 5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromid) was added to each well and the plates were incubated at 37 ºC for 2 h. 
Then the MTT solution was removed from each well and replaced with 400 µL isopropanol to 
dissolve the generated blue-violet insoluble formazan. After swaying, the plates were placed in a 
micro-plate reader and readings were obtained at 570 nm and 650 nm. The quantity of formazan 
product can be measured by the following equation (Equation 1), which is directly proportional to 
the number of living cells in each culture:  
OD = OD570 – OD65                                                                                                             (Equation 1) 
where OD570 and OD650 are the mean values of the measured optical density of the test sample at 
570 and 650 nm, respectively. 
 
Results and Discussion 
Electrospun webs of PCL and P11-8 were successfully produced and the nano- and microscale 
structures were studied to elucidate morphology, chemical composition, peptide distribution, 
molecular peptide conformation, wettability and cytotoxic response.  
Secondary conformation of peptide. It was intended to incorporate the peptide within the 
spinning solution in its monomeric form, such that changes in concentration during electrospinning 
and solvent evaporation could potentially elicit β-sheet formation. CD and FTIR analysis were 
conducted to identify the conformation of P11-8 before (in solution) and after electrospinning (in as-
spun fibres) (Figure 1). The CD spectrum of the P11-8 solution prior to spinning displays a negative 
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minimum at around 195 nm and a positive maximum at around 210 nm (Figure 1A), which is 
consistent with the random coil peptide conformation in the solution reported previously.
51
 This 
explanation is supported by the lack of a negative band at 218 nm, which would be characteristic of 
a β-sheet conformation.6, 48 Additionally, a slight shift in wavelength and intensity of the peptide 
bands was observed when comparing the obtained spectra with previously reported CD plots.
6, 48
 
 
Figure 1. Secondary structure analysis of P11-8 before and after electrospinning in the solution and in the as-
spun fibres. (A) CD spectrum of PCL/P11-8 solution in HFIP, (B) FTIR amide Iʹ bands of electrospinning 
solution of PCL/P11-8 in HFIP, (C) ATR-FTIR amide Iʹ bands of electrospun fibres of PCL/P11-8 fibres. The 
concentration of peptide herein is 20 mg∙mL-1 (sample 3). 
 
This effect is likely to be related to the much higher concentration of peptide used in the 
electrospinning solution (20 mg∙mL-1) compared to the average concentration previously analysed 
during CD spectroscopy of P11-X peptides (0.15 mg∙mL
-1
) as well as the presence of PCL. FTIR 
analysis of the PCL/P11-8 solution (Figure 1B) was in agreement with the CD data, whereby a broad 
peak was observed at around 1650 cm
-1
, confirming a random coil configuration,
48
 due to the HFIP-
triggered breakdown of hydrogen bonds along the peptide molecules.
31, 47
 The ATR-FTIR spectra 
for electrospun PCL/P11-8 fibres are shown in Figure 1C. The presence of the peak at 1630 cm
-1
 
along with peaks at 1617 cm
-1 
and 1683 cm
-1 
gives supporting evidence of the predominant anti 
parallel β-sheet conformation of peptide in the fibres.6, 48 At the same time, a very small peak at 
1650 cm
-1 
is observed in the FTIR spectrum of peptide-encapsulated electrospun fibres, suggesting 
the presence of a non-assembled peptide fraction in the fibres. Thus, the random coiled P11-8 
present in the PCL spinning solution is likely to self-assemble during electrospinning to yield 
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predominant β-sheet conformation in the collected fibres. This is the result of the critical peptide 
concentration (c*) being reached during electrospinning due to solvent evaporation.  
Fibre morphology. Electrospinning of the commixed PCL and P11-8 peptide (Figure 2, C-H) 
induced detectable changes in fibre morphology as compared to spinning solutions based on PCL 
only (Figure 2, A-B). PCL fibres were homogenously distributed in terms of shape and diameter. In 
contrast, the webs containing both PCL and P11-8 consisted of two superimposed fibre networks of 
submicron (100-700 nm) and nanofibres (10-100 nm). The fibre diameter distribution of PCL and 
PCL/P11-8 (sample 1 and 3) is shown in Figure 3A and B. Note that the overall range of fibre 
diameters was greater for PCL/P11-8 compared to the PCL control. In addition to the wide range of 
fibre diameters and the two distinct diameter distributions in fibres containing P11-8, there is a 
decrease in the mean of submicron fibre region (Mean= 296.4 nm; Standard Error: 6.2 nm), 
compared to the PCL control (Mean = 386.9 nm; Standard Error: 5.6 nm). This observed shift can 
be attributed to an increase in conductivity of the polymer solution due to the peptide content (P11-8 
with +2 net charge), and therefore a likely increase in surface charge density of the jet during 
spinning, which causes a decrease in fibre diameter.
52, 53
 
By increasing the concentration of P11-8 in PCL solution to 10, 20 and 40 mg∙mL
-1
, the extent of 
the nanofibrous architecture present in the webs progressively increased (Figure 2), providing a 
convenient way of customising the nonwoven structure at the nanoscale. The nanofibres with 
diameter of 10-100 nm connected to the surrounding submicron parent fibres (Figure 2) were 
comparable in dimensions to P11-8 fibrils reported in self-assembled gels.
2, 6
 Moreover, some 
regions (e.g. in Figure 2C and E) revealed rope-like fibres that are consistent with aggregation of 
single β-sheet-ordered peptide tapes48 or double twisted fibres at the submicron scale resembling the 
molecular orientation of single β-sheet tapes stacking face to face to form twisted fibrils.3, 6  
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Figure 2. Scanning Electron Micrographs of samples 1 (A, B), 2 (C, D), 3 (E, F) and 4 (G, H). The scale bar 
in all images is 1 micron. By increasing the P11-8 concentration in the electrospinning solution the degree of 
secondary superimposed nanofibre network (10-100 nm) formation increases amongst the submicron fibres 
(100-700 nm). 
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Based on these SEM observations and previous CD and FTIR spectra, it is likely that peptide 
assembly (from an unordered conformation to β-sheet) occurs during electrospinning of the solution 
by reaching the critical peptide concentration (c*) as a result of solvent evaporation. Ultimately 
further increase in peptide concentration triggers peptide monomers to self-assemble into structures 
of higher hierarchical assembly such as fibrils and bundled fibrils (fibres), following complete 
solvent removal in collected fibres. Such “spider-net” nanofibre architecture among submicron 
fibres has previously been reported by Pant et al.
54
 for nylon-6 nanofibres as a result of hydrogen 
bond formation during fibre production. During electrospinning of peptides in the present study, 
renaturation of hydrogen bonds associated with peptide molecules, previously broken down by the 
presence of HFIP in solution,
55
 could potentially promote the formation of a fibrillar network. 
Moreover the formation of electrospun spider-net like nanofibres has been related to an increase in 
conductivity of the spinning solution elsewhere caused by, for example, the addition of salts or 
secondary interactions between neighbouring molecules.
54, 56-62
 In this study, P11-8 peptide includes 
arginine residue at position 3, ornithine (-(CH2)3NH2) residue at positions 5 and 7 and a glutamic 
acid unit at position 9 (Figure 3C). The side chains of arginine and ornithine are positively charged, 
whilst glutamic acid is negatively charged in solution resulting in an overall +2 net electrostatic 
charge.
6, 8
 It can theoretically be assumed that by addition of P11-8 into pure PCL solution, the 
electrical conductivity of the solution can increase and this has been shown in previous studies 
45
. 
Therefore the progressive increase in the extent of nanofibre architecture (10-100 nm) with 
increasing peptide concentration is likely to be attributed to secondary repulsion effects between 
peptide monomers in neighbouring charged groups.  
Peptide distribution within the fibrous structure. To verify the presence of peptide within the 
fibres, Energy Dispersive X-Ray Spectroscopy (EDX) was applied in conjunction with SEM and 
TEM. An example of the SEM-EDX spectra of the PCL fibres (sample 1) and PCL/P11-8 at medium 
peptide concentration (sample 3) are shown in Figure 4A and B. The nitrogen peak, which can be 
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attributed solely to the peptide, is observed in the PCL/P11-8 spectrum with weight percentage of 8 
± 3%, compared to 0% nitrogen in the PCL control fibres. The EDX was also performed on sample 
2, which was prepared with the lowest concentration of peptide (peptide concentration: 10 mg.mL
-
1
). The results did not indicate any detectable nitrogen content. This is in line with the fact that EDX 
cannot detect the presence of light elements (such as nitrogen) at concentration lower than 8 wt%.  
 
Figure 3. (A-B): Fibre diameter distributions of (A) samples 1 and (B) 3. (C) Peptide primary structure of 
P11-8 carrying a +2 net electrostatic charge. 
 
In addition to SEM-EDX, high resolution TEM images of the nano- and micro-scale fibres in the 
webs were obtained. Figure 4C shows a typical submicron fibre (diameter around 300 nm) and a 
single connected nanofibre (diameter around 50 nm) in sample 3 and EDX spectroscopy was 
applied to each of these fibres and confirmed nitrogen contents of 6 ± 1% and 4 ± 1%, respectively. 
The statistically insignificant variation of peptide-related nitrogen content on both fibrous networks 
only verifies that there is peptide present in both thick and thin fibres. The fact that TEM-EDX was 
carried out in 100% vacuum mode excludes the possibility of detecting environmental nitrogen 
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residue. These observations are indicative of the incorporation of peptide within both the larger 
submicron (100-700 nm) and nanofibre architecture (10-100 nm), providing evidence of the 
absence of phase separation between PCL and the peptide during electrospinning.  
CLSM micrographs of electrospun sample containing fluorescent peptides (sample 5) are shown 
in Figure 4D. No fluorescence background was detected in the PCL control in contrast to the 
PCL/P11-8 sample where individual fibres were clearly visible confirming incorporation of P11-8 
throughout the entire fibrous structure, in agreement with the SEM and TEM elemental analysis.  
 
Figure 4. SEM/EDX analysis of electrospun fibres (A) sample 1 showing no nitrogen content and (B) 
sample 3 showing 8 ± 3% nitrogen content. (C) TEM/EDX analysis of sample 3; both submicron fibres and 
nanofibres were observed, whereby nitrogen content could be quantified. (D) Confocal laser scanning 
micrograph of fluorescently labelled electrospun fibres (sample 5) confirming the incorporation of peptide 
throughout the fibres. 
 
Surface wettability. Given that water represents most of the weight fraction of the extracellular 
matrix of biological tissues, the contact angles of electrospun webs made of PCL and PCL/P11-8 
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were measured via application of either deionised water or DMEM. Water and DMEM droplets on 
the surface of the webs (sample 1, 2 and 3) are shown in Figure 5 (A-F) at time = 0 s.  
 
Figure 5. Initial contact angle of electrospun fibre webs following application of a droplet of either deionised 
water (A, C, E) or DMEM (B, D, F) on sample 1 (A, B), 2 (C, D)  and 3 (E, F). Dynamic contact angle 
measurements on electrospun fibre webs for 15 s, droplet of both deionised water (G) and DMEM (H).  
18 
 
The contact angles on sample 4 could not be imaged and measured because of the rapid penetration 
of the droplet into the structure due to its hydrophilicity. Contact angles greater than 90° were 
observed on electrospun PCL, whilst decreased contact angle values were measured as P11-8 
concentration (0-20 mg∙mL-1) increased. This effect may be beneficial in order to promote cell 
adhesion and proliferation in PCL-based materials.
63
  To improve the characterisation of wettability 
analysis in such porous samples, the rate of wetting was determined using goniometry, wherein 
several contact angles are measured as a function of time (duration of 15s).
64
 Figure 5G and H show 
the dynamic contact angle for water and DMEM on the surfaces of sample 1, 2 and 3. Interestingly, 
the rate of wettability was found to progressively increase as the concentration of P11-8 increased 
from 0 to 20 mg∙mL-1. The surface of electrospun webs comprises solid fibres and pores such that 
the resulting discontinuities can also potentially influence wetting behaviour. However, when films 
were made from the same electrospinning solutions and dried for 48 h at room temperature under 
vacuum, the observed contact angles were found to follow the same trend as the electrospun 
samples. As with the electrospun samples, the hydrophilicity improved with increasing peptide 
concentration from 0 up to 20 mg. mL
-1
. This corresponded with contact angles ranging from θ = 
79° to θ = 18°. The data are shown in the supporting information, Figure S1. 
Direct cytotoxicity assay. The cell response of L929 mouse fibroblasts when cultured in contact 
with sample 3 and sample 1 (negative control) fibre webs was assessed. Two typical images 
showing L929 cells in contact with both samples are shown in Figure 6A and B. A spread-like 
morphology was observed in cells cultured in direct contact with samples with and without P11-8, 
such that fibroblasts proliferated up to and in contact with both the negative control and P11-8-
containing samples (dark areas are the edges of the webs). These morphologies can be verified by 
comparing with the morphology of cells that have been cultured in DMEM only as a control (data 
are provided in supplementary information Figure S2). These microscopic observations were 
supplemented by a MTT metabolic assay in order to quantify cell viability. MTT is metabolically 
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reduced in viable cells to a blue-violet insoluble formazan. This assay (Figure 6C) revealed a 
comparable number of viable cells in contact with PCL/P11-8 sample and the PCL and DMEM 
controls, whilst a significantly lower number of viable cells is detected in DMSO (positive control). 
Therefore, no evidence of a cytotoxic response could be discerned in the PCL/P11-8 fibre web 
samples.    
 
Figure 6. Light microscopy images of L929 cells in contact with sample 1 (A) and 3 (B). (C) OD absorption 
of samples at 570-650 nm correlated to the number of viable cells. 
 
Conclusions 
One-step assembly of a multiscale fibrous network containing micro-, nano- and in-situ molecular 
self-assembled P11-8 peptide fibres was successfully demonstrated by electrospinning of a PCL-
monomeric P11-8 commixture. SEM, TEM and CLSM revealed a bimodal fibre diameter 
distribution of superimposed nano- and microscale fibre networks, both of which contain P11-8 
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peptide. Analysis of the spinning solution and as-spun fibres by CD and FTIR revealed a switch 
from monomeric to predominant β-sheet peptide conformation, confirming that electrospinning 
process was able to trigger the molecular self-assembly mechanism and induce nanofibre formation. 
The hydrogen bonding-mediated self-assembly of P11-8 during electrospinning, and the transition 
from a solution to fibre state, is most likely related to the rapid solvent evaporation and the resultant 
marked increase in the peptide concentration within the fibres (above c*). Although it is reasonable 
to assume that most of the solvent evaporation-driven self-assembly occurs via the solvent jet from 
the nozzle tip to the collector, it is possible that changes in peptide conformation continue if 
residual solvent is present in the deposited fibres. Adjusting the peptide concentration in the 
electrospinning solution was found to be a useful means of systematically customising the internal 
nanoscale structure of the webs, providing a convenient way of controlling nonwoven architecture 
at the nanoscale. The wide range of fibre diameters in samples containing P11-8 may be beneficial in 
applications such as drug delivery where staggered release of multiple drugs is desirable. The 
combined micro- and nanofibrous architecture may also facilitate a controlled degradation profile in 
bicomponent scaffolds, since the nanofibres can be expected to degrade more quickly than the 
larger diameter fibres and therefore gradual degradation of the peptide component incorporated into 
submicron structures. Moreover, the presence of the biofunctional peptide among the submicron 
fibre pores could promote endogenous cell homing within the core of the material, which is crucial 
for functional tissue regeneration. Incorporation of P11-8 in PCL enhanced hydrophilicity and 
proved to be well tolerated by mouse fibroblast cells. In light of these results, ongoing 
investigations are also focusing on the degradation kinetics and release profile of the peptide from 
the electrospun webs as well as the bioactivity of resulting materials for potential applications in 
bone/dental tissue repair.  
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Supporting Information 
 
  
  
Figure S1. Contact angle of water on PCL and PCL/P11-8 cast films showing enhanced hydrophilicity with 
increased peptide concentration. 
 
 
Figure S2. Light microscopy image of L929 cells cultured in DMEM as a control sample. Scale bar ~ 200 
µm. 
 
100% PCL, Θo = 79 ± 3° PCL/P11-8 (10 mg), Θo = 59 ± 2° 
PCL/P11-8 (20 mg), Θo = 18 ± 3° 
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